Rationale for a combined use of antiretroviral and immunomodulatory therapies in HIV infection
- 31 December 1991
- journal article
- Published by Elsevier in International Journal of Immunopharmacology
- Vol. 13, 43-48
- https://doi.org/10.1016/0192-0561(91)90123-o
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- The Efficacy of Inosine Pranobex in Preventing the Acquired Immunodeficiency Syndrome in Patients with Human Immunodeficiency Virus InfectionNew England Journal of Medicine, 1990
- Inhibition of HIV progression by dithiocarbPublished by Elsevier ,1990
- INOSINE PRANOBEX AND ZIDOVUDINE METABOLISMThe Lancet, 1989
- HIV with Reduced Sensitivity to Zidovudine (AZT) Isolated During Prolonged TherapyScience, 1989
- Combinations of isoprinosine and 3'-azido-3'-deoxythymidine in lymphocytes infected with human immunodeficiency virus type 1Antimicrobial Agents and Chemotherapy, 1988
- RANDOMISED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL OF DITIOCARB SODIUM ('IMUTHIOL') IN HUMAN IMMUNODEFICIENCY VIRUS INFECTIONThe Lancet, 1988
- The Efficacy of Azidothymidine (AZT) in the Treatment of Patients with AIDS and AIDS-Related ComplexNew England Journal of Medicine, 1987
- AIDS Retrovirus Induced Cytopathology: Giant Cell Formation and Involvement of CD4 antigenScience, 1986
- IN-VITRO INHIBITION OF LAV/HTLV-III INFECTED LYMPHOCYTES BY DITHIOCARB AND INOSINE PRANOBEXThe Lancet, 1985
- Isolation of a T-Lymphotropic Retrovirus from a Patient at Risk for Acquired Immune Deficiency Syndrome (AIDS)Science, 1983